NeuroOne Medical Technologies 

$2.03
28
-$0.12-5.58% Friday 20:00
+$0.28+13.79%Friday 23:39After hours

Statistics

Day High
2.07
Day Low
2.03
52W High
6.96
52W Low
1.423
Volume
575
Avg. Volume
-
Mkt Cap
18.48M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.25
-0.15
-0.04
0.06
Expected EPS
-0.23
Actual EPS
N/A

Financials

-39.62%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
9.1MRevenue
-3.61MNet Income

Analyst Ratings

4.83Average Price Target
The highest estimate is 8.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NMTC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.83B
Medtronic is a major player in the medical device industry, offering products that compete directly with NeuroOne's neurotechnology solutions.
Abbott Laboratories
ABT
Mkt Cap192.51B
Abbott Laboratories provides a wide range of medical devices, including neurostimulation devices that compete with NeuroOne's offerings.
Smith & Nephew
SNN
Mkt Cap12.48B
Smith & Nephew operates in the medical technology sector, offering products that can compete in the neurosurgical space.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific Corporation offers innovative medical solutions, including neuromodulation devices that rival NeuroOne's technologies.
Stryker
SYK
Mkt Cap130.11B
Stryker Corporation is a leading medical technology company with products that compete in the neurotechnology and neurosurgical markets.
Zimmer Biomet
ZBH
Mkt Cap19.2B
Zimmer Biomet Holdings, Inc. provides various medical devices that, while primarily focused on orthopedics, also ventures into areas that can compete with NeuroOne.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its medical devices segment, offers products that can compete across a broad range of medical device categories, including neuro.
Intuitive Surgical
ISRG
Mkt Cap139.37B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, a field that intersects with NeuroOne's focus on advanced surgical technologies.
Edwards Lifesciences
EW
Mkt Cap52.8B
Edwards Lifesciences Corporation is known for its heart disease treatments but also invests in technology that could compete in the broader medical device market.
Integra Lifesciences
IART
Mkt Cap1.43B
Integra LifeSciences Holdings Corporation offers products for neurosurgery, directly competing with NeuroOne's neurotechnology solutions.

About

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Show more...
CEO
David A. Rosa
Employees
18
Country
United States
ISIN
US64130M3088

Listings

0 Comments

Share your thoughts

FAQ

What is NeuroOne Medical Technologies stock price today?
The current price of NMTC is $2.03 USD — it has decreased by -5.58% in the past 24 hours. Watch NeuroOne Medical Technologies stock price performance more closely on the chart.
What is NeuroOne Medical Technologies stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange NeuroOne Medical Technologies stocks are traded under the ticker NMTC.
Is NeuroOne Medical Technologies stock price growing?
NMTC stock has risen by +4.64% compared to the previous week, the month change is a +5.18% rise, over the last year NeuroOne Medical Technologies has showed a -56.88% decrease.
What is NeuroOne Medical Technologies market cap?
Today NeuroOne Medical Technologies has the market capitalization of 18.48M
When is the next NeuroOne Medical Technologies earnings date?
NeuroOne Medical Technologies is going to release the next earnings report on December 16, 2026.
What is NeuroOne Medical Technologies revenue for the last year?
NeuroOne Medical Technologies revenue for the last year amounts to 9.1M USD.
What is NeuroOne Medical Technologies net income for the last year?
NMTC net income for the last year is -3.61M USD.
How many employees does NeuroOne Medical Technologies have?
As of August 22, 2026, the company has 18 employees.
In which sector is NeuroOne Medical Technologies located?
NeuroOne Medical Technologies operates in the Health & Wellness sector.
When did NeuroOne Medical Technologies complete a stock split?
The last stock split for NeuroOne Medical Technologies was on April 16, 2026 with a ratio of 1:6.
Where is NeuroOne Medical Technologies headquartered?
NeuroOne Medical Technologies is headquartered in EDEN PRAIRIE, United States.